# DESCRIPTION

## STATEMENT OF GOVERNMENT INTEREST

- acknowledge government support

## BACKGROUND OF THE INVENTION

- motivate myocardial infarction treatment

## SUMMARY OF THE INVENTION

- introduce cyclic peptide composition

## DETAILED DESCRIPTION OF THE INVENTION

- define terms and abbreviations

### Definitions

- define articles and conjunctions
- define "comprising", "including", and "having"
- define "and/or"
- define "consisting" and "consisting essentially of"
- define ranges and numerical values
- define "about"
- define "patient" or "subject"
- define "pharmaceutical composition" and "pharmaceutically acceptable"
- define "therapeutically effective" and "treatment"

## EXAMPLES

- introduce cyclic peptide progelators
- design of stimuli-responsive SAPs for activatable gelation in vivo
- cyclization and progelator formulation
- cyclic progelators are responsive to inflammation associated enzymes
- progelators assemble as viscoelastic and rehealable hydrogels despite robust proteolysis
- catheter compatibility of cyclic peptide progelators
- hemocompatibility and intramyocardial injections in a rat myocardial infarction model
- in vivo gelation and proof-of-concept analyses
- demonstrate progelator in vivo
- describe platform modification strategy
- illustrate versatility of platform
- discuss development of smart materials
- provide general information and materials
- detail peptide synthesis and analysis
- describe experimental methods
- detail transmission electron microscopy
- outline light scattering measurements
- explain experimental circular dichroism
- describe computational modeling with FibPredictor
- detail theoretical CD spectra with DichroCalc
- outline in vitro enzyme cleavage of cyclic peptide progelator
- describe rheological characterization

